AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BICYCLE THERAPEUTICS PLC Director's Dealing 2025

Jan 7, 2025

32777_dirs_2025-01-06_93657165-254b-4354-bbc1-73206490e7a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BICYCLE THERAPEUTICS PLC (BCYC)
CIK: 0001761612
Period of Report: 2025-01-02

Reporting Person: Kender Richard N (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-02	Ordinary Shares	A	6250	—	Acquired	23000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-02	Stock Option (right to buy)	$14	A	12500	Acquired	2035-01-02	Ordinary Shares (12500)	Direct

Footnotes

F1: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025.

F2: Each RSU represents a contingent right to receive one ordinary share.

F3: This option shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025.